A Radiosensitivity Gene Signature and PD-L1 Status Predict Clinical Outcome of Patients with Glioblastoma Multiforme in The Cancer Genome Atlas Dataset

PURPOSE: Combination of radiotherapy and immune checkpoint blockade such as programmed death-1 (PD-1) or programmed death-ligand 1 (PD-L1) blockade is being actively tested in clinical trial. We aimed to identify a subset of patients that could potentially benefit from this strategy using The Cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Bum-Sup, Kim, In Ah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176964/
https://www.ncbi.nlm.nih.gov/pubmed/31801317
http://dx.doi.org/10.4143/crt.2019.440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176964/
https://www.ncbi.nlm.nih.gov/pubmed/31801317
http://dx.doi.org/10.4143/crt.2019.440

Ejemplares similares